REFERENCES
- Aaseth J., Alexander J., Norseth T. Uptake of 51Cr-chromate by human erythrocytes-a role of glutathione. Acta Pharmacol Toxicol (Copenh.) 1982; 50(4)310–315, [CSA]
- Alexander J., Aaseth J. Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier. Analyst 1995; 120(3)931–933, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Attenburrow M. J., Mitter P. R., Whale R., Terao T., Cowen P. J. Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology 2002; 159(4)432–436, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bagchi D., Vuchetich P. J., Bagchi M., Hassoun E. A., Tran M. X., Tang L., Stohs S. J. Induction of oxidative stress by chronic administration of sodium dichromate [chromium VI] and cadmium chloride [cadmium II] to rats. Free Radic. Biol. Med 1997; 22(3)471–478, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bagchi D., Bagchi M., Stohs S. J. Chromium (VI)-induced oxidative stress, apoptotic cell death and modulation of p53 tumor suppressor gene. Mol. Cell Biochem 2001; 222(1–2)149–158, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Biedermann K. A., Landolph J. R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res. 1987; 47(14)3815–3823, [PUBMED], [INFOTRIEVE], [CSA]
- Biedermann K. A., Landolph J. R. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis, and anchorage independence in diploid human fibroblasts. Cancer Res 1990; 50(24)7835–7842, [PUBMED], [INFOTRIEVE], [CSA]
- Borneff J., Engelhardt K., Griemm W, Kuntem H, Reichert J. Carcinogens in water and soil. XXII. Experiment with 3,4-benzopyrene and potassium chromate in mice drink. Arch. Hyg. Bakteriol 1968; 152(1)45–53, [PUBMED], [INFOTRIEVE], [CSA]
- Bridgewater L. C., Manning F. C., Patierno S. R. Base-specific arrest of in vitro DNA replication by carcinogenic chromium: Relationship to DNA interstrand crosslinking. Carcinogenesis 1994; 15(11)2421–2427, [PUBMED], [INFOTRIEVE], [CSA]
- Bridgewater L. C., Manning F. C., Patierno S. R. Arrest of replication by mammalian DNA polymerases alpha and beta caused by chromium-DNA lesions. Mol. Carcinogen 1998; 23(4)201–206, [CROSSREF], [CSA]
- Capellmann M., Mikalsen A., Hindrum M., Alexander J. Influence of reducing compounds on the formation of DNA–protein cross-links in HL-60 cells induced by hexavalent chromium. Carcinogenesis 1995; 16(5)1135–1139, [PUBMED], [INFOTRIEVE], [CSA]
- Chen J., Thilly W. G. Use of denaturing-gradient gel electrophoresis to study chromium-induced point mutations in human cells. Environ. Health Perspect. 1994; 102(Suppl 3)227–229, [PUBMED], [INFOTRIEVE], [CSA]
- Chuang S. M., Liou G. Y., Yang J. L. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 2000; 21(8)1491–1500, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cohen M. D., Kargacin B., Klein C. B., Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 1993; 23(3)255–281, [PUBMED], [INFOTRIEVE], [CSA]
- Costa M. Toxicity and carcinogenicity of Cr(VI) in animal models and humans. Crit. Rev. Toxicol 1997; 27(5)431–442, [PUBMED], [INFOTRIEVE], [CSA]
- Costa M. Potential hazards of hexavalent chromate in our drinking water. Toxicol. Appl. Pharmacol 2003; 188(1)1–5, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Costa M., Zhitkovich A., Harris M., Paustenbauch D., Gargas M. DNA–protein cross-links produced by various chemicals in cultured human lymphoma cells. J. Toxicol. Environ. Health 1997; 50(5)433–449, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Costa M., Salnikow K., Sutherland J. E., Broday L., Peng W., Zhang Q., Kluz T. The role of oxidative stress in nickel and chromate genotoxicity. Mol. Cell. Biochem 2002; 234–235(1–2)265–275, [CROSSREF], [CSA]
- Cupo D. Y., Wetterhahn K. E. Modification of chromium(VI)-induced DNA damage by glutathione and cytochromes P-450 in chicken embryo hepatocytes. Proc. Natl. Acad. Sci. USA 1985; 82(20)6755–6759, [PUBMED], [INFOTRIEVE], [CSA]
- Davidson T. L., Kluz T., Burns F. J., Rossman T. G., Zhang Q., Uddin A., Nadas A., Costa M. Exposure to chromium (VI) in the drinking water increases susceptibility to UV-induced skin tumors in hairless mice. Toxicol. Appl. Pharmacol 2004; 196(3)431–437, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000; 21(4)533–541, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Flora S., Camoirano A., Bagnasco M., Bennicelli C., Corbett G. E., Kerger B. D. Estimates of the chromium(VI) reducing capacity in human body compartments as a mechanism for attenuating its potential toxicity and carcinogenicity. Carcinogenesis 1997; 18(3)531–537, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Feng Z., Hu W., Rom W. N., Costa M., Tang M. S. Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon–DNA binding at the p53 gene in human lung cells. Carcinogenesis 2003; 24(4)771–778, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Franklin M., Odontiadis J. Effects of treatment with chromium picolinate on peripheral amino acid availability and brain monoamine function in the rat. Pharmacopsychiatry 2003; 36(5)176–180, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gibb H. J., Lees P. S.J., Pinsky P. F., Rooney B. Lung cancer among workers in chromium chemical production. Am. J. Ind. Med 2000; 38(2)115–126, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Grimsrud T. K., Berge S. R., Martinsen J. I., Andersen A. Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. J. Environ. Monit. 2003; 5(2)190–197, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hartwig A., Beyersmann D. Comutagenicity and inhibition of DNA repair by metal ions in mammalian cells. Biol. Trace Elem. Res 1989; 21: 359–365, [PUBMED], [INFOTRIEVE], [CSA]
- Hu W., Feng Z., Tang M. S. Chromium(VI) enhances (+/−)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydro benzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair. Biochemistry 2004; 43(44)14282–14289, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- IARC. Chromium and chromium compounds. IARC Monogr. Eval. Carcinogen. Risk Chem. Hum 1980; 23: 205–323, [CSA]
- Kerger B. D., Paustenbach D. J., Corbett G. E., Finley B. L. Absorption and elimination of trivalent and hexavalent chromium in humans following ingestion of a bolus dose in drinking water. Toxicol. Appl. Pharmacol 1996; 141(1)145–158, [PUBMED], [INFOTRIEVE], [CSA]
- Kerger B. D., Finley B. L., Corbett G. E., Dodge D. G., Paustenbach D. J. Ingestion of chromium(VI) in drinking water by human volunteers: Absorption, distribution, and excretion of single and repeated doses. J. Toxicol. Environ. Health 1997; 50(1)67–95, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kuschner M., Laskin S. Experimental models in environmental carcinogenesis. Am. J. Pathol 1971; 64(1)183–196, [PUBMED], [INFOTRIEVE], [CSA]
- Kuykendall J. R., Kerger B. D., Jarvi E. J., Corbett G. E., Paustenbach D. J. Measurement of DNA–protein cross-links in human leukocytes following acute ingestion of chromium in drinking water. Carcinogenesis 1996; 17(9)1971–1977, [PUBMED], [INFOTRIEVE], [CSA]
- Långard S. One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 1990; 17(2)189–215, [CSA]
- Manning F. C., Patierno S R. Apoptosis: inhibitor or instigator of carcinogenesis?. Cancer Invest 1996; 14(5)455–465, [PUBMED], [INFOTRIEVE], [CSA]
- Menvielle G., Luce D., Fevotte J., Bugel I., Salomon C., Goldberg P., Billon-Galland M. A., Goldberg M. Occupational exposures and lung cancer in New Caledonia. Occup. Environ. Med 2003; 60(8)584–589, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mertz W. Chromium research from a distance: from 1959 to 1980. J. Am. Coll. Nutr 1998; 17(6)544–547, [PUBMED], [INFOTRIEVE], [CSA]
- Park R. M., Bena J. F., Stayner L. T., Smith R. J., Gibb H. J., Lees P. S. Hexavalent chromium and lung cancer in the chromate industry: A quantitative risk assessment. Risk Anal 2004; 24(5)1099–1108, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Patierno S. R., Banh D., Landolph J. R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 1988; 48(18)5280–5288, [PUBMED], [INFOTRIEVE], [CSA]
- Paustenbach D. J., Hays S. M., Brien B. A., Dodge D. G., Kerger B. Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking water. J. Toxicol. Environ. Health 1996; 49(5)453–461, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Paustenbach D. J., Finley B. L., Mowat F. S., Kerger B. D. Human health risk and exposure assessment of chromium(VI) in tap water. J. Toxicol. Environ. Health A 2003; 66(14)1295–1339, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Petrilli F. L., De Flora S. Metabolic reduction of chromium as a threshold mechanism limiting its in vivo activity. Sci. Total Environ 1988; 71(3)357–364, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Proctor D. M., Otani J. M., Finley B. L., Paustenbach D. J., Bland J. A., Speizer N., Sargent E. V. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review. J. Toxicol. Environ. Health A 2002; 65(10)701–746, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rhodes M. C., Hebert C. D., Herbert R. A., Morinello E. J., Roycroft J. H., Travalos G. S., Abdo K. M. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium piccolinate monohydrate. Food Chem. Toxicol 2005; 43: 21–29, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Salnikow K., Zhitkovich A., Costa M. Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. Carcinogenesis 1992; 13(12)2341–2346, [PUBMED], [INFOTRIEVE], [CSA]
- Shi X. G., Sun X. L., Gannett P. M., Dalal N. S. Deferoxamine inhibition of Cr(V)-mediated radical generation and deoxyguanine hydroxylation: ESR and HPLC evidence. Arch. Biochem. Biophys. 1992; 293(2)281–286, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shi X., Mao Y., Knapton A. D., Ding M., Rojanasakul Y., Gannett P. M., Dalal N., Liu K. Reaction of Cr(VI) with ascorbate and hydrogen peroxide generates hydroxyl radicals and causes DNA damage: Role of a Cr(IV)-mediated Fenton-like reaction. Carcinogenesis 1994; 15(11)2475–2478, [PUBMED], [INFOTRIEVE], [CSA]
- Slesinski R. S., Clarke J. J., San R. H.C., Gudi R. Lack of mutagenicity of chromium piccolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res 2005; 585(1–2)86–95, [PUBMED], [INFOTRIEVE], [CSA]
- Sugiyama M. Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radical Biol. Med 1992; 12(5)397–407, [CROSSREF], [CSA]
- Sugiyama M., Patierno S. R., Cantoni O, Costa M. Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells. Mol. Pharmacol. 1986; 29(6)606–613, [PUBMED], [INFOTRIEVE], [CSA]
- Suzuki Y. Reduction of hexavalent chromium by ascorbic acid in rat lung lavage fluid. Arch. Toxicol. 1988; 62(2–3)116–122, [PUBMED], [INFOTRIEVE], [CSA]
- Travacio M., Polo J. M., Llesuy S. Chromium(VI) induces oxidative stress in the mouse brain. Toxicology 2000; 150(1–3)137–146, [PUBMED], [INFOTRIEVE], [CSA]
- Travacio M., Polo J. M., Llesuy S. S. Chromium(VI) induces oxidative stress in the mouse brain. Toxicology 2001; 162(2)139–148, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ueno S., Kashimoto T., Susa N., Furukawa Y., Ishii M., Yokoi K., Yasuno M., Sasaki Y. F., Ueda J., Nishimura Y., Sugiyama M. Detection of dichromate (VI)-induced DNA strand breaks and formation of paramagnetic chromium in multiple mouse organs. Toxicol. Appl. Pharmacol. 2001; 170(1)56–62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- U.S. Environmental Protection Agency. Chromium Compounds. 1992, http://www.epa.gov/ttn/atw/hlthef/chromium.html
- U.S. Occupational Safety and Health Administration. 2000, 29CFR1910.1000, Table Z-2
- Vincent J. B. Recent developments in the biochemistry of chromium(III). Biol. Trace Elem. Res 2004; 99(1–3)1–16, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Voitkun V., Zhitkovich A., Costa M. Complexing of amino acids to DNA by chromate in intact cells. Environ. Health Perspect 1994; 102(Suppl. 3)251–255, [PUBMED], [INFOTRIEVE], [CSA]
- Voitkun V., Zhitkovich A., Costa M. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res 1998; 26(8)2024–2030, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wesseling C., Pukkala E., Neuvonen K., Kauppinen T., Boffetta P., Partanen T. Cancer of the brain and nervous system and occupational exposures in Finnish women. J. Occup. Environ. Med. 2002; 44(7)663–668, [PUBMED], [INFOTRIEVE], [CSA]
- Wetterhahn K. E., Hamilton J. W. Molecular basis of hexavalent chromium carcinogenicity: Effect on gene expression. Sci. Total Environ 1989; 86(1–2)113–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang J. D., Li X. L. Chromium pollution of soil and water in Jinzhou. Zhonghua Yu Fang Yi Xue Za Zhi 1987; 21(5)262–264, [PUBMED], [INFOTRIEVE], [CSA]
- Zhang J. D., Li S. Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J. Occup. Environ. Med 1997; 39(4)315–319, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhang Q., Kluz T., Salnikow K., Costa M. Comparison of the cytotoxicity, cellular uptake, and DNA–protein crosslinks induced by potassium chromate in lymphoblast cell lines derived from three different individuals. Biol. Trace Elem. Res 2002; 86(1)11–22, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhitkovich A. Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI). Chem. Res. Toxicol 2005; 18(1)3–11, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhitkovich A., Voitkun V., Costa M. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 1995; 16(4)907–913, [PUBMED], [INFOTRIEVE], [CSA]
- Zhitkovich A., Voitkun V., Costa M. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: Importance of trivalent chromium and the phosphate group. Biochemistry 1996; 35(22)7275–7282, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhitkovich A., Song Y., Quievryn G., Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: Role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 2001; 40(2)549–560, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]